American Samoa Community Cancer Coalition Ua o gatasi le futia me le umele.

MIT engineers have built a device that gives them an unprecedented view of three-dimensional cell growth and migration, including the formation of blood vessels and the spread of tumor cells.

MIT engineers have developed carbon nanotubes into sensors for cancer drugs and other DNA-damaging agents inside living cells. The sensors can detect chemotherapy drugs as well as environmental toxins and free radicals that damage DNA.

In work that represents a fundamental shift in scientists' understanding of DNA transcription, MIT researchers have found evidence that two DNA copying machines frequently start from the same site and move in different directions.

On Nov. 24, MIT students will show off their robotic engineering skills. They have been building robotic arms and writing software that will allow them to remotely make an incision in a silicone "organ" and remove a jelly bean masquerading as a tumor.

MIT biologists have discovered that the organization of DNA's packing material plays a critical role in directing stem cells to become different types of adult cells. The work could also shed light on the possible role of DNA packaging in cancer development.

MIT engineers have outfitted cells with tiny "backpacks" that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering.

Scientists have long known it's possible for one gene to produce slightly different forms of the same protein. Now, an MIT team has shown that this phenomenon, is far more prevalent and varies more between tissues than was previously believed.

Mammalian cells with extra chromosomes share some common traits that could be exploited to develop cancer treatments. Having too many chromosomes, a condition known as aneuploidy, seems to confer an advantage on tumor cells

MIT researchers have custom designed nanoparticles that can deliver the cancer drug cisplatin specifically to prostate cancer cells. The new research was published online in the Proceedings of the National Academy of Sciences last week.

After spending years developing a model to help illuminate cell signaling pathways, a team of MIT researchers decided to "break" the model, yielding information that could maximize the effectiveness of treatments such as chemotherapy.

An MIT team has shown that even the simplest behaviors of the tiny roundworm can be controlled by multiple signaling pathways. The results might have implications for the treatment of human brain disorders.

MIT researchers have shown that cells from different people don't all react the same way when exposed to the same DNA-damaging agent -- a finding that could help clinicians predict how patients will respond to chemotherapy.

Researchers at MIT's Bates Linear Accelerator Center have begun a collaboration with Texas-based ProTom International to develop and test a new cancer treatment based on proton therapy.